XENETIC BIOSCIENCES, INC. Earnings Per Share (Basic)
XENETIC BIOSCIENCES, INC. (XBIO) reported Earnings Per Share (Basic) of -$0.41 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- XENETIC BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.41.
- XENETIC BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.20.
- XENETIC BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.33.
- XENETIC BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.45.
- XENETIC BIOSCIENCES, INC. earnings per share, basic for fiscal 2025 was -$1.58.
- XENETIC BIOSCIENCES, INC. earnings per share, basic for fiscal 2024 was -$2.57.
- XENETIC BIOSCIENCES, INC. earnings per share, basic for fiscal 2023 was -$2.71.
- XENETIC BIOSCIENCES, INC. earnings per share, basic for fiscal 2022 was -$4.61.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.41 10-Q · filed 2026-08-06 | -$0.60 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | -$0.20 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | -$1.58 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | -$0.33 10-Q · filed 2025-11-12 | -$1.36 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | -$0.45 10-Q · filed 2026-08-06 | -$1.03 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | -$0.59 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | -$2.57 10-K · filed 2026-03-12 | |||||||
| 2024-09-30 | -$0.28 10-Q · filed 2025-11-12 | -$1.89 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | -$0.83 10-Q · filed 2025-08-12 | -$1.60 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | -$0.78 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | -$2.71 10-K · filed 2025-03-18 | |||||||
| 2023-09-30 | -$0.69 10-Q · filed 2024-11-12 | -$1.94 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | -$0.69 10-Q · filed 2024-08-13 | -$1.25 10-Q · filed 2024-08-13 | ||||||
| 2023-03-31 | -$0.56 10-Q · filed 2024-05-09 | -$0.06 10-Q · filed 2023-05-11 | ||||||
| 2022-12-31 | -$4.61 10-K · filed 2024-03-21 | -$0.46 10-K · filed 2023-03-22 | ||||||
| 2022-09-30 | -$0.56 10-Q · filed 2023-11-09 | -$0.06 10-Q · filed 2022-11-09 | -$3.64 10-Q · filed 2023-11-09 | -$0.36 10-Q · filed 2022-11-09 | ||||
| 2022-06-30 | -$1.90 10-Q · filed 2023-08-10 | -$0.19 10-Q · filed 2022-08-11 | -$3.10 10-Q · filed 2023-08-10 | -$0.31 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | -$0.12 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | -$0.55 10-K · filed 2023-03-22 | |||||||
| 2021-09-30 | -$0.13 10-Q · filed 2022-11-09 | -$0.41 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | -$0.13 10-Q · filed 2022-08-11 | -$0.28 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |